Search Results

Treating the Growing Population of Patients With High-Risk, Complex Coronary Artery Disease: Protected PCI With Impella®

By Seth Bilazarian, MD, FACC, FSCAI

Evolving Evidence for Protected PCI With Impella® to Treat High-Risk Complex CAD Patients

PROTECT clinical studies consistently demonstrate MACCE reduction at 90 days.

By Seth Bilazarian, MD, FACC, FSCAI

Expanding Your Patient Practice With a Protected PCI™ Program: Treating the Most Complex Patients

Protected PCI™ provides a new treatment option for patients with complex coronary artery disease and gives physicians the opportunity to perform complete revascularization on high-risk patients.

By Seth Bilazarian, MD, FACC, FSCAI